Amaferm
Commercial- Indications
- Animal nutrition
Company intelligence / Profile preview
BioZyme
St. Joseph, Missouri, United Statesbiozymeinc.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BioZyme has over seven decades of research-driven innovation in animal nutrition. Its proprietary AO-Biotics Amaferm ingredient has been validated in more than 175 published studies to improve digestibility and overall wellness across cattle, swine, poultry, sheep, goats, horses, dogs, cats and more. The company’s supplements are widely used globally for improved animal performance.
- Therapeutic areas
- GastroenterologyMetabolic DisordersOther
- Modalities
- PrebioticPost-bioticFeed additive
- Industry
- Veterinary
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on BioZyme.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioZyme.